Medifast Statistics
Total Valuation
Medifast has a market cap or net worth of $128.97 million. The enterprise value is -$17.25 million.
Important Dates
The next confirmed earnings date is Monday, April 28, 2025, after market close.
| Earnings Date | Apr 28, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Medifast has 10.66 million shares outstanding. The number of shares has increased by 0.39% in one year.
| Current Share Class | 10.66M |
| Shares Outstanding | 10.66M |
| Shares Change (YoY) | +0.39% |
| Shares Change (QoQ) | +0.11% |
| Owned by Insiders (%) | 2.45% |
| Owned by Institutions (%) | 77.51% |
| Float | 9.49M |
Valuation Ratios
The trailing PE ratio is 63.68.
| PE Ratio | 63.68 |
| Forward PE | n/a |
| PS Ratio | 0.22 |
| Forward PS | 0.29 |
| PB Ratio | 0.62 |
| P/TBV Ratio | 0.61 |
| P/FCF Ratio | 7.58 |
| P/OCF Ratio | 5.27 |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.08.
| Current Ratio | 3.34 |
| Quick Ratio | 2.53 |
| Debt / Equity | 0.08 |
| Debt / EBITDA | 0.68 |
| Debt / FCF | 0.95 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 1.02% and return on invested capital (ROIC) is 4.27%.
| Return on Equity (ROE) | 1.02% |
| Return on Assets (ROA) | 3.24% |
| Return on Invested Capital (ROIC) | 4.27% |
| Return on Capital Employed (ROCE) | 6.99% |
| Revenue Per Employee | $1.20M |
| Profits Per Employee | $4,149 |
| Employee Count | 504 |
| Asset Turnover | 2.03 |
| Inventory Turnover | 3.25 |
Taxes
In the past 12 months, Medifast has paid $1.70 million in taxes.
| Income Tax | 1.70M |
| Effective Tax Rate | 44.78% |
Stock Price Statistics
The stock price has decreased by -62.88% in the last 52 weeks. The beta is 1.08, so Medifast's price volatility has been similar to the market average.
| Beta (5Y) | 1.08 |
| 52-Week Price Change | -62.88% |
| 50-Day Moving Average | 13.87 |
| 200-Day Moving Average | 17.23 |
| Relative Strength Index (RSI) | 36.78 |
| Average Volume (20 Days) | 237,334 |
Short Selling Information
The latest short interest is 1.38 million, so 12.97% of the outstanding shares have been sold short.
| Short Interest | 1.38M |
| Short Previous Month | 1.39M |
| Short % of Shares Out | 12.97% |
| Short % of Float | 14.56% |
| Short Ratio (days to cover) | 6.77 |
Income Statement
In the last 12 months, Medifast had revenue of $602.46 million and earned $2.09 million in profits. Earnings per share was $0.19.
| Revenue | 602.46M |
| Gross Profit | 444.62M |
| Operating Income | 15.38M |
| Pretax Income | 37.29M |
| Net Income | 2.09M |
| EBITDA | 18.90M |
| EBIT | 15.38M |
| Earnings Per Share (EPS) | $0.19 |
Full Income StatementBalance Sheet
The company has $162.34 million in cash and $16.13 million in debt, giving a net cash position of $146.22 million or $13.72 per share.
| Cash & Cash Equivalents | 162.34M |
| Total Debt | 16.13M |
| Net Cash | 146.22M |
| Net Cash Per Share | $13.72 |
| Equity (Book Value) | 210.11M |
| Book Value Per Share | 19.71 |
| Working Capital | 150.24M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $24.48 million and capital expenditures -$7.45 million, giving a free cash flow of $17.02 million.
| Operating Cash Flow | 24.48M |
| Capital Expenditures | -7.45M |
| Free Cash Flow | 17.02M |
| FCF Per Share | $1.60 |
Full Cash Flow StatementMargins
Gross margin is 73.80%, with operating and profit margins of 2.55% and 0.35%.
| Gross Margin | 73.80% |
| Operating Margin | 2.55% |
| Pretax Margin | 0.63% |
| Profit Margin | 0.35% |
| EBITDA Margin | 3.14% |
| EBIT Margin | 2.55% |
| FCF Margin | 2.83% |
Dividends & Yields
Medifast does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.39% |
| Shareholder Yield | -0.39% |
| Earnings Yield | 1.62% |
| FCF Yield | 13.20% |
Dividend DetailsAnalyst Forecast
The average price target for Medifast is $16.50, which is 36.36% higher than the current price. The consensus rating is "Hold".
| Price Target | $16.50 |
| Price Target Difference | 36.36% |
| Analyst Consensus | Hold |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Medifast has an Altman Z-Score of 6.23 and a Piotroski F-Score of 6.
| Altman Z-Score | 6.23 |
| Piotroski F-Score | 6 |